IMMUNOCORE HOLDINGS PLC
13119746Activities of other holding companies n.e.c.
IMMUNOCORE HOLDINGS PLC
Activities of other holding companies n.e.c.
Previous Company Names
Contact & Details
Contact
Full company profile for IMMUNOCORE HOLDINGS PLC (13119746), an active life sciences and medical technology company based in United Kingdom. Incorporated 7 Jan 2021. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2018–2025)
Cash in Bank
£864.15M
Net Assets
£381.03M
Total Liabilities
£686.24M
Turnover
£419.74M
Employees
524
Debt Ratio
64%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 31 Dec Year End | 2024 31 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| John Irving Bell | Director | British,canadian | United Kingdom | 7 Jan 2021 | Active |
| Roy Steven Herbst | Director | American | United States | 28 Jan 2021 | Active |
See all 11 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
John Irving Bell
Ceased 22 Jan 2021
Group Structure
Group Structure
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 22 Jun 2026 | Miscellaneous | Replacement filing of SH01 - 17/03/26 Statement of Capital gbp 102239.8041 | |
| 22 Jun 2026 | Miscellaneous | Replacement filing of SH01 - 25/03/26 Statement of Capital gbp 102241.9021 | |
| 17 Jun 2026 | Accounts | Annual accounts made up to 31 Dec 2025 | |
| 8 Jun 2026 | Capital | Allotment of shares (GBP 102,618.9281) on 22 May 2026 | |
| 12 May 2026 | Capital | Allotment of shares (GBP 102,310.4981) on 23 Apr 2026 |
Replacement filing of SH01 - 17/03/26 Statement of Capital gbp 102239.8041
Replacement filing of SH01 - 25/03/26 Statement of Capital gbp 102241.9021
Annual accounts made up to 31 Dec 2025
Allotment of shares (GBP 102,618.9281) on 22 May 2026
Allotment of shares (GBP 102,310.4981) on 23 Apr 2026
Recent Activity
Latest Activity
Replacement filing of SH01 - 17/03/26 Statement of Capital gbp 102239.8041
4 days ago on 22 Jun 2026
Replacement filing of SH01 - 25/03/26 Statement of Capital gbp 102241.9021
4 days ago on 22 Jun 2026
Annual accounts made up to 31 Dec 2025
1 weeks ago on 17 Jun 2026
Allotment of shares (GBP 102,618.9281) on 22 May 2026
2 weeks ago on 8 Jun 2026
Allotment of shares (GBP 102,310.4981) on 23 Apr 2026
1 months ago on 12 May 2026